{ "cik": 1762303, "cik_padded": "0001762303", "entityName": "AVITA Medical, Inc.", "fiscal_years": [ { "accn": "0001193125-26-049031", "filed": "2026-02-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1005000.0, "cash": 10243000.0, "cost_of_revenue": 12794000.0, "eps_diluted": -1.74, "free_cash_flow": -32200000.0, "gross_profit": 58816000.0, "net_income": -48587000.0, "operating_cash_flow": -31195000.0, "operating_income": -42534000.0, "revenue": 71610000.0, "stockholders_equity": -16650000.0, "total_assets": 56392000.0, "total_liabilities": 73042000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8213378019829632, "net_margin": -0.678494623655914, "operating_margin": -0.5939673229995811, "revenue_growth_yoy": 0.1145351823317925, "roa_avg2y": -0.7139739755920149, "roa_period_end": -0.8615938430983118, "roe_avg2y": 7.9972018763887744 } }, { "accn": "0001193125-26-049031", "filed": "2026-02-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9171000.0, "cash": 14050000.0, "cost_of_revenue": 9094000.0, "eps_diluted": -2.39, "free_cash_flow": -58110000.0, "gross_profit": 55157000.0, "net_income": -61845000.0, "operating_cash_flow": -48939000.0, "operating_income": -56593000.0, "revenue": 64251000.0, "stockholders_equity": 4499000.0, "total_assets": 79711000.0, "total_liabilities": 74968000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8584613469051066, "leverage": 16.66325850188931, "net_margin": -0.9625531120138207, "operating_margin": -0.8808111936000996, "revenue_growth_yoy": 0.28135532377400635, "roa_avg2y": -0.6464037292723842, "roa_period_end": -0.7758653134448195, "roe_avg2y": -2.3095882737372793 } }, { "accn": "0001193125-26-049031", "filed": "2026-02-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1381000.0, "cash": 22118000.0, "cost_of_revenue": 7780000.0, "eps_diluted": -1.4, "free_cash_flow": -39392000.0, "gross_profit": 42363000.0, "net_income": -35381000.0, "operating_cash_flow": -38011000.0, "operating_income": -42655000.0, "revenue": 50143000.0, "stockholders_equity": 49056000.0, "total_assets": 111640000.0, "total_liabilities": 61891000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8448437468839121, "leverage": 1.2616397586431833, "net_margin": -0.7056019783419419, "operating_margin": -0.8506670921165467, "revenue_growth_yoy": 0.45675605008570347, "roa_avg2y": -0.33711601494016313, "roa_period_end": -0.31692045861698315, "roe_avg2y": -0.5288797871386289 } }, { "accn": "0000950170-25-020026", "filed": "2025-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 452000.0, "cash": 18164000.0, "cost_of_revenue": 6041000.0, "eps_diluted": 1.07, "free_cash_flow": -19542000.0, "gross_profit": 28380000.0, "net_income": -26665000.0, "operating_cash_flow": -19090000.0, "operating_income": -27505000.0, "revenue": 34421000.0, "stockholders_equity": 84740000.0, "total_assets": 98264000.0, "total_liabilities": 12967000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8244966735423143, "leverage": 0.15302100542836913, "net_margin": -0.7746724383370617, "operating_margin": -0.7990761453763691, "revenue_growth_yoy": 0.17751094690749863, "roa_avg2y": -0.2488811316087904, "roa_period_end": -0.2713608239029553, "roe_avg2y": -0.28162691958344777 } }, { "accn": "0001564590-23-002302", "filed": "2024-02-22", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 894000.0, "cash": 55511000.0, "cost_of_revenue": 5949000.0, "eps_diluted": 1.17, "free_cash_flow": -26795000.0, "gross_profit": 23283000.0, "net_income": -26583000.0, "operating_cash_flow": -25901000.0, "operating_income": -26540000.0, "revenue": 29232000.0, "stockholders_equity": 104624000.0, "total_assets": 116015000.0, "total_liabilities": 11391000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.7964901477832512, "leverage": 0.10887559259825662, "net_margin": -0.90938013136289, "operating_margin": -0.9079091406677614, "revenue_growth_yoy": 1.049498702937671, "roa_avg2y": -0.26786982874590004, "roa_period_end": -0.22913416368573028, "roe_avg2y": -0.3003304617991809 } }, { "accn": "0001564590-23-002302", "filed": "2023-02-23", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 590000.0, "cash": 73639000.0, "cost_of_revenue": 2973000.0, "eps_diluted": 2.07, "free_cash_flow": -23337000.0, "gross_profit": 11290000.0, "net_income": -42030000.0, "operating_cash_flow": -22747000.0, "operating_income": -42679000.0, "revenue": 14263000.0, "stockholders_equity": 72401000.0, "total_assets": 82462000.0, "total_liabilities": 10061000.0 }, "period_end": "2020-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.7915585781392414, "leverage": 0.1389621690308145, "revenue_growth_yoy": 1.6055900621118013, "roa_avg2y": -0.7765644919904662, "roa_period_end": -0.5096893114404211, "roe_avg2y": -0.9016120901397574 } }, { "accn": "0001564590-21-045962", "filed": "2021-08-26", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1021000.0, "cash": 20174000.0, "cost_of_revenue": 1271000.0, "eps_diluted": 1.56, "free_cash_flow": -20271000.0, "gross_profit": 4203000.0, "net_income": -25102000.0, "operating_cash_flow": -19250000.0, "operating_income": -25528000.0, "revenue": 5474000.0, "stockholders_equity": 20832000.0, "total_assets": 25784000.0, "total_liabilities": 4952000.0 }, "period_end": "2019-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.767811472415053, "leverage": 0.23771121351766514, "revenue_growth_yoy": 4.892357373519914, "roa_period_end": -0.9735494880546075, "roe_avg2y": -1.439995410738871 } }, { "accn": "0001564590-21-045962", "filed": "2021-08-26", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 365000.0, "cost_of_revenue": 546000.0, "eps_diluted": 1.37, "free_cash_flow": -13325000.0, "gross_profit": 383000.0, "net_income": -12735000.0, "operating_cash_flow": -12960000.0, "operating_income": -13841000.0, "revenue": 929000.0, "stockholders_equity": 14032000.0 }, "period_end": "2018-06-30", "ratio_units": { "gross_margin": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.41227125941872983, "roe_avg2y": -1.4180724903958577 } }, { "accn": "0001193125-20-233145", "filed": "2020-08-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 3929000.0 }, "period_end": "2017-06-30", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-049031", "filed": "2026-02-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001762303.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001762303.json" }, "ticker": "RCEL" }